News

Obesity Does Not Increase Risk for Ovarian Cancer Recurrence

Obesity Does Not Increase Risk for Ovarian Cancer Recurrence

May 29, 2012

05/29/2012 Research that will be presented at the 2012 American Society of Clinical Oncology meeting June 1-5th suggests that obesity did not affect recurrence, time to recurrence, or progression-free survival in women with epithelial ovarian cancer following surgery and chemotherapy. Previous research examining the relationship between obesity and ovarian cancer has yielded mixed results. Click … Continued

Removing Fallopian Tubes Reduces Risk of Ovarian Cancer

Removing Fallopian Tubes Reduces Risk of Ovarian Cancer

May 11, 2012

Based on data showing that removing a woman’s fallopian tubes removes her risk of developing ovarian cancer, doctors are now urging women who are having their tubes tied to have them removed, instead. There is an increasing body of evidence suggesting that ovarian cancer may start in the fallopian tubes. Surgery to remove the fallopian … Continued

DNA Repair Genes May be a Predictor of Ovarian Cancer Survival

DNA Repair Genes May be a Predictor of Ovarian Cancer Survival

April 30, 2012

04/30/2012   Research published this month in the Journal of the National Cancer Institute suggests that DNA repair genes may be a predictor of ovarian cancer survival. Researchers at Dana-Farber Cancer Institute in Boston used gene expression data from The Cancer Genome Atlas database to develop a molecular “score” by looking at genes involved in … Continued

Increased BMI and Height Tied to Ovarian Cancer Risk

Increased BMI and Height Tied to Ovarian Cancer Risk

April 16, 2012

04/16/2012 Research reported in the journal PLoS Medicine finds that a woman’s Body Mass Index (BMI) and height are both tied to her risk for ovarian cancer.  Regardless of a woman’s height and size, her risk of developing ovarian cancer remains very small. Researchers from the United Kingdom included data from more than 25,000 women … Continued

Draft USPSTF Statement Recommends Against Ovarian Cancer Sc...

Draft USPSTF Statement Recommends Against Ovarian Cancer Screening

April 11, 2012

04/11/2012   In a draft statement released April 11, 2012, the U.S. Preventive Services Task Force (USPSTF) again stated that screening average-risk women for ovarian cancer does more harm than good. The USPSTF, an independent volunteer panel of non-government experts in prevention and evidence-based medicine, is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, … Continued

Updates from the Society of Gynecologic Oncology Meeting

Updates from the Society of Gynecologic Oncology Meeting

April 3, 2012

04/03/2012 Members of OCRF’s senior staff and Scientific Advisory Committee recently attended the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer in Austin, TX. Now in its 43rd year, the Annual Meeting on Women’s Cancer continues to be the premier educational activity for women’s cancer care professionals. Data Confirm PARP Inhibitor Slows Ovarian … Continued

OCRF Invited to Participate in Important New National Resea...

OCRF Invited to Participate in Important New National Research Initiative

March 6, 2012

03/06/2012   The U.S. Preventive Services Task Force (USPSTF), an independent volunteer panel of non-government experts in prevention and evidence-based medicine, is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, and nurses). This prestigious group conducts rigorous scientific reviews of a broad range of clinical preventive health care services (such as screening, counseling, … Continued

OCRF Research Defines Association Between Ovarian Cancer an...

OCRF Research Defines Association Between Ovarian Cancer and Endometriosis

February 22, 2012

02/22/2012   Research by a team of scientists funded by OCRF has shown that there is an association between invasive ovarian cancer and endometriosis.  The research was reported on February 22nd in Lancet Oncology. The Ovarian Cancer Association Consortium, a collaborative created with the support of OCRF and led by grantee Dr. Andrew Berchuck, conducted an analysis … Continued

OCRF Research Explains High Platelets and Reduced Survival ...

OCRF Research Explains High Platelets and Reduced Survival in Ovarian Cancer Patients

February 17, 2012

02/17/2012 An international team of researchers led by OCRF grantee Anil Sood, MD has found that elevated platelet levels in ovarian cancer patients fuel tumor growth and reduce survival. These findings reveal a new factor in cancer progression and a possible new approach for treatment. The study, which was reported in the New England Journal of Medicine, was … Continued

OCRF Research Provides Further Evidence that Ovarian Cancer...

OCRF Research Provides Further Evidence that Ovarian Cancer Originates in Fallopian Tube

February 16, 2012

02/16/2012   Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences. Little is known about how ovarian cancer starts and spreads. Recent … Continued

Study Finds BRCA Mutation Boosts Ovarian Cancer Survival

Study Finds BRCA Mutation Boosts Ovarian Cancer Survival

January 27, 2012

01/27/2012   A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than … Continued

New Study Evaluates Usefulness of New Symptom Indices

New Study Evaluates Usefulness of New Symptom Indices

January 24, 2012

01/24/2012 The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but these indices may need to be reassessed in order to help better detect cancer, according to a study … Continued